Activities of Ramona STRUGARIU related to 2023/2157(DEC)
Shadow reports (1)
REPORT on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction for the financial year 2022
Shadow opinions (1)
OPINION on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction for the financial year 2022
Amendments (2)
Amendment 1 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Notes from the Court’s report that the Centre, although it paid interest for only one late payment, had a significant number of payments wrongly flagged as late (107 out of 1 595) by the Centre’s financial and accounting management (ABAC) because of the incorrect parametrisations and/or incorrect data inputs regarding the due date of payment or the reception of the documents entailing a payment obligation; notes from the Centre’s reply that the inconsistent flagging of late payments did not affect the regularity of the operations involved; notes further that the Centre has adopted some measures to minimize the referred risk for ‘false positive’ and to further ensure that its ABAC system may provide for a clear and accurate picture of the actual late payments; calls on the Agency to continue to monitor this issue and mitigate possible future reputational risks associated to this issue;
Amendment 2 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Notes with appreciation that in 2022 the Centre released a new rapid mixed-method trendspotter study to assess the initial service response to the needs of displaced Ukrainians in neighbouring countries within the Union; commends the Centre for collaborating with Europol for preparing the fourth edition of the joint EU Drug Markets: In-depth analysis, the findings of which are presented in a series of modules, each focusing on the market for a particular drug and covering trends along the supply chain from production and trafficking to distribution and use; commends in this context the launch in 2022 of the first two modules on cocaine and methamphetamine;